NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
03. Juni 2021 07:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021
20. Mai 2021 08:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
26. April 2021 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...
NeuroPace, Inc. Announces Pricing of Initial Public Offering
21. April 2021 20:45 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...